See also this year's filing and all EDGAR filings for this company.
PDF Report 0000810509_2022_Navidea_Biopharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Revenues', 'missing_ratio': 0.0007238229886181185, 'aggregate_val': 531513, 'exp_sum': 531898, 'exp_to_value': {'remainder_Revenues': 531898}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000810509')"} |
Graph
Absolute values for 0000810509, Navidea Biopharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 20,288 |
| 1 | LiabilitiesCurrent | 5,299,802 |
| 2 | remainder_Liabilities | 700,000 |
| 3 | AssetsCurrent | 5,383,285 |
| 4 | AssetsNoncurrent | 355,407 |
| 5 | PropertyPlantAndEquipmentNet | 120,490 |
| 6 | Goodwill | 785,651 |
| 7 | remainder_Assets | 0 |
| 8 | GeneralAndAdministrativeExpense | 7,450,015 |
| 9 | ResearchAndDevelopmentExpense | 5,141,910 |
| 10 | remainder_Expenses | 16,043 |
| 11 | remainder_Revenues | 531,513 |
| 12 | remainder_NetIncome | 345,524 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 6,020,090 |
| 1 | Assets | 6,644,833 |
| 2 | Expenses | 12,607,968 |
| 3 | Revenues | 531,513 |
| 4 | StockholdersEquity | 624,743 |
| 5 | NetIncome | -11,730,931 |
| 6 | ComprehensiveNetIncome | -11,730,931 |
| 7 | BaseVar | 13,074,964 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.72 |
| 9 | EconomicCapitalRatio | 0.439 |
Edgar->Model Mapping
Feature Distribution
Change over Time
